Methotrexate Injection, Solution
Product Images NDC 63323-123

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 63323-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Met16 0002 01)

Chemical structure diagram of Methotrexate Sodium showing its molecular components and bonds as part of a pharmaceutical labeling image.*

FDA Label Image

Logo (Met16 0002 02)

FDA Label Image

Vial (Met16 0002 03)

Methotrexate Injection, USP 25 mg per mL (250 mg per 10 mL) sterile isotonic liquid in a 10 mL vial. The label states it contains preservative benzyl alcohol 0.9% w/v, is cytotoxic, and is not for intrathecal use. Labeled for intra-arterial, intramuscular, and intravenous routes. Manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Carton (Met16 0002 04)

Label for Methotrexate Injection, USP, 250 mg per 10 mL (25 mg per mL) solution. The label indicates it contains preservative and is a cytotoxic agent. It includes a warning that it is not for intrathecal use and advises consulting the package insert for routes of administration. The vial size is 10 mL, and the labeler is Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.